Perrigo to release Q2 2026 financial results on August 5
Perrigo Company plc will release its second quarter 2026 financial results on Wednesday, August 5, 2026. A conference call hosted by Interim President and CEO Albert Manzone and CFO Eduardo Bezerra will follow at 8:30 a.m. EST. The call will be available via webcast and phone, with a replay accessible until August 12, 2026.

*this image is generated using AI for illustrative purposes only.
Perrigo Company plc will release its second quarter 2026 financial results on Wednesday, August 5, 2026. The company will hold a conference call beginning at 8:30 a.m. EST to discuss the performance, hosted by Interim President and CEO Albert Manzone and CFO Eduardo Bezerra.
Conference Call Details
The earnings call will be accessible live via webcast through the investor relations section of the Perrigo website. Participants may also join by phone using the following numbers and conference ID:
| Region | Phone Number | Conference ID |
|---|---|---|
| U.S. | 800-836-8184 | 98476 |
| International | 646-357-8785 | 98476 |
A replay of the call will be available beginning at approximately 12:00 p.m. EST on August 5, 2026, through Wednesday, August 12, 2026. To access the replay, dial 888-660-6345 (U.S.) or 646-517-4150 (International) and enter access code 98476 #.
About Perrigo Company plc
Perrigo Company plc is a leading pure-play self-care company with over a century of experience in providing high-quality health and wellness solutions to consumers primarily in North America and Europe. The company operates as a pioneer in the over-the-counter (OTC) self-care market, offering trusted solutions that do not require a prescription. Perrigo's business model leverages cash-generative store brand private label offerings to fuel investments for leading brands, including Opill®, Mederma®, Compeed®, EllaOne®, and Jungle Formula®.
How will Perrigo's Q2 2026 financial results reflect the performance of its key brands like Opill® and Mederma®?
What strategic initiatives might Interim CEO Albert Manzone highlight during the call to drive future growth?
How is Perrigo positioning itself to capitalize on trends in the self-care and OTC markets in North America and Europe?

























